- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by EmCyte Corporation
Total 6493 results
-
Incyte CorporationRecruitingAdvanced Solid TumorsSpain, United Kingdom, Italy, France, Belgium, Hungary
-
Incyte CorporationRecruitingAngioedema | Urticaria | Chronic Idiopathic Urticaria | Pruritis | Chronic Spontaneous Urticaria | HivesUnited States, Germany, Poland
-
Incyte CorporationRecruitingMelanoma | Hepatocellular Carcinoma (HCC) | Renal Cell Carcinoma (RCC) | Colorectal Carcinoma (CRC) | Microsatellite Instability - High (MSI-H) | Mismatch Repair Deficient (dMMR)United States, Canada, South Africa, Mexico
-
Incyte CorporationRecruitingModerate to Severe AsthmaKorea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
-
Incyte CorporationRecruitingKidney Diseases | Renal InsufficiencyUnited States, Germany
-
Incyte CorporationRecruitingHidradenitis Suppurativa (HS)United States, Canada, Bulgaria, Italy, Spain, Germany, Poland, France, Australia, Denmark, United Kingdom
-
Incyte CorporationRecruitingAdvanced MalignanciesSpain, United States, France, Italy, Belgium
-
Incyte CorporationRecruitingDiffuse Large B-Cell Lymphoma | Large B-Cell LymphomaCroatia, Serbia, Czechia, Finland, Israel, Romania, Denmark, Hungary, Ireland, Poland, Turkey, Bulgaria, Norway, United Kingdom
-
Incyte CorporationRecruitingFibrodysplasia Ossificans Progressiva (FOP)United States, France, Korea, Republic of, Spain, Italy, United Kingdom, Russian Federation, China, Australia, Brazil, Mexico, New Zealand, Argentina, Canada, Netherlands, Turkey, Chile, Germany, South Africa, Portugal
-
Incyte CorporationRecruitingB-Cell MalignanciesUnited States, Spain, Belgium, Japan, Italy, France, United Kingdom, Israel, Turkey, Norway, Korea, Republic of, Czechia, Sweden, Austria, Poland, Hungary, Denmark
-
Incyte CorporationTerminatedAdvanced MalignanciesUnited States, Italy, Denmark, Japan
-
Incyte CorporationTerminatedMPN (Myeloproliferative Neoplasms)United States
-
Incyte CorporationActive, not recruiting
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Canada
-
Incyte CorporationActive, not recruitingMetastatic Merkel Cell CarcinomaUnited Kingdom, United States, Germany, Canada, Czechia, Italy, France, Spain, Switzerland, Australia, Poland, Hungary
-
Incyte CorporationActive, not recruitingHand EczemaUnited States, Poland, Canada, Germany
-
Incyte CorporationCompletedCytokine Release SyndromeUnited States
-
Incyte CorporationCompletedHepatocellular Carcinoma | Colorectal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Triple Negative Breast Cancer | Pancreatic Ductal Adenocarcinoma | Castration Resistant Prostate Cancer | Gastric/ Gastroesophageal Junction | Squamous Carcinoma...United States, Spain, France, United Kingdom, Italy, Belgium
-
Incyte CorporationActive, not recruitingMyelodysplastic Syndromes | Multiple Myeloma | AnemiaUnited States, France, Italy
-
Incyte CorporationActive, not recruitingLocally Advanced Solid Tumors | Metastatic Solid TumorsFrance, Spain, United States, China, United Kingdom, Lithuania, Germany, Ukraine, Finland, Italy, Belgium, Australia, Bulgaria, Latvia, New Zealand, Poland
-
Incyte CorporationCompletedNon-Small Cell Lung Cancer (NSCLC)Spain, United States, Italy, Germany, France
-
Incyte CorporationActive, not recruitingBreast Cancer | Pancreatic Cancer | Lung Cancer | Colorectal Cancer (CRC)United States
-
Incyte CorporationAvailableSTAT1 Gain-of-Function Disease
-
Incyte CorporationCompletedVitiligoUnited States, Canada, Poland, Spain, Germany, Bulgaria, France, Netherlands
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)Belgium, Italy, Spain, Saudi Arabia, Turkey, United Kingdom, Germany, Greece, Canada, Austria, France, Israel, Netherlands, Sweden, Switzerland, Korea, Republic of, Bulgaria, Japan, Norway, Czechia, Russian Federation, Jordan, Hungary, Ind... and more
-
Incyte CorporationTerminatedSolid Tumors and Hematologic MalignancyUnited States, Netherlands, Belgium
-
Incyte CorporationCompletedHemodialysis | Renal ImpairmentUnited States
-
Incyte CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany
-
Incyte CorporationCompletedCholangiocarcinomaUnited States, France, Italy, United Kingdom, Germany, Taiwan, Spain, Belgium, Israel, Korea, Republic of, Japan, Thailand
-
Incyte CorporationCompletedUnresectable or Metastatic Solid TumorsUnited States
-
Incyte CorporationWithdrawnHand EczemaUnited States, Germany, Spain, Czechia, Canada, Poland
-
Incyte CorporationWithdrawnChronic Hand Eczema (CHE)United States, Canada, Spain, Germany, Czechia, Poland, Bulgaria
-
Incyte CorporationCompleted
-
Incyte CorporationCompletedNon-segmental VitiligoUnited States, Spain, Canada, France, Poland, Bulgaria, Germany, Italy
-
Incyte CorporationCompletedAdvanced MalignanciesUnited States
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)United States
-
Incyte CorporationTerminatedHematologic MalignanciesUnited States, Spain, France, Italy
-
Incyte CorporationWithdrawn
-
Incyte CorporationTerminatedSolid TumorsUnited States, Belgium, France
-
Incyte CorporationCompleted
-
Incyte CorporationCompletedAcute Lymphoblastic Leukemia | BCR-ABL Positive | Philadelphia PositiveItaly
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)Canada, United States, Australia
-
Incyte CorporationCompleted
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Canada
-
Incyte CorporationCompletedAtopic DermatitisUnited States
-
Incyte CorporationTerminatedRelapsed Ewing SarcomaUnited States, Spain, United Kingdom, Italy
-
Incyte CorporationTerminatedNasopharyngeal Cancer | Esophageal Cancer | Ovarian Cancer | Hepatocellular Carcinoma (HCC) | Cholangiocarcinoma | Solid TumorsUnited States, Belgium
-
Incyte CorporationWithdrawn
-
Incyte CorporationCompleted
-
Incyte CorporationCompletedA Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic DermatitisAtopic DermatitisUnited States, Canada